For instance, it has been demonstrated that the inhibition of Crm1 and Importin-β1 in cervical cancer cells reduced cell proliferation, making both proteins promising candidates as both biomarkers and potential anticancer therapeutic targets (van der Watt et al., 2009). Here, XPO1 is linked to cervical carcinoma.